SG11202003784TA - Biomarkers of preterm birth - Google Patents
Biomarkers of preterm birthInfo
- Publication number
- SG11202003784TA SG11202003784TA SG11202003784TA SG11202003784TA SG11202003784TA SG 11202003784T A SG11202003784T A SG 11202003784TA SG 11202003784T A SG11202003784T A SG 11202003784TA SG 11202003784T A SG11202003784T A SG 11202003784TA SG 11202003784T A SG11202003784T A SG 11202003784TA
- Authority
- SG
- Singapore
- Prior art keywords
- biomarkers
- preterm birth
- preterm
- birth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201708890Y | 2017-10-30 | ||
PCT/EP2018/079639 WO2019086410A1 (en) | 2017-10-30 | 2018-10-30 | Biomarkers of preterm birth |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202003784TA true SG11202003784TA (en) | 2020-05-28 |
Family
ID=64049256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202003784TA SG11202003784TA (en) | 2017-10-30 | 2018-10-30 | Biomarkers of preterm birth |
Country Status (13)
Country | Link |
---|---|
US (1) | US20200319197A1 (pt) |
EP (1) | EP3704270A1 (pt) |
JP (1) | JP2021501343A (pt) |
KR (1) | KR20200094742A (pt) |
CN (1) | CN111542619A (pt) |
AU (1) | AU2018357888A1 (pt) |
BR (1) | BR112020008605A2 (pt) |
CA (1) | CA3080456A1 (pt) |
IL (1) | IL274325A (pt) |
MX (1) | MX2020004421A (pt) |
SG (1) | SG11202003784TA (pt) |
TW (1) | TW201923347A (pt) |
WO (1) | WO2019086410A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3150506A1 (en) * | 2019-09-22 | 2021-03-25 | Erick GARCIA CORDERO | DEVICE AND METHOD FOR ASSESSING RISK OF PREMATURE BIRTH |
CN111951969A (zh) * | 2020-08-05 | 2020-11-17 | 中翰盛泰生物技术股份有限公司 | Hbp在高危妊娠预测中的应用 |
CN112708653B (zh) * | 2020-11-26 | 2023-06-16 | 中国科学技术大学 | 一种用月经血预测反复流产和/或诊断反复流产的原因的检测方法 |
WO2023152203A1 (en) * | 2022-02-10 | 2023-08-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for prediction and monitoring of spontaneous preterm birth |
WO2024015934A2 (en) * | 2022-07-13 | 2024-01-18 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods of diagnostic screening and early detection of adenomyosis |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8068990B2 (en) * | 2003-03-25 | 2011-11-29 | Hologic, Inc. | Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids |
US20050255114A1 (en) * | 2003-04-07 | 2005-11-17 | Nuvelo, Inc. | Methods and diagnosis for the treatment of preeclampsia |
US20080090759A1 (en) * | 2004-08-30 | 2008-04-17 | Robert Kokenyesi | Methods and kits for predicting risk for preterm labor |
KR20150003157A (ko) * | 2005-12-19 | 2015-01-08 | 트러스티즈 오브 터프츠 칼리지 | 소프트 단백질분해효소 억제자 및 이의 프로-소프트 폼 |
US8828981B2 (en) * | 2007-02-06 | 2014-09-09 | George Creasy | Progesterone for the treatment or prevention of spontaneous preterm birth |
CN102056611A (zh) * | 2008-04-14 | 2011-05-11 | Posi维森纳里解决方案有限责任公司 | 用于获得不同的治疗适应症所需要的血浆孕酮水平的方法和药物组合物 |
WO2009134452A2 (en) * | 2008-05-01 | 2009-11-05 | Swedish Health Services | Preterm delivery diagnostic assay |
WO2010006070A1 (en) * | 2008-07-08 | 2010-01-14 | The Trustees Of The University Of Pennsylvania | Method for assessment of folate phenotypes, disease risk, and response to therapy |
US20140186332A1 (en) * | 2012-12-28 | 2014-07-03 | NX Pharmagen | Biomarkers of preterm birth |
EP2972308B9 (en) * | 2013-03-15 | 2021-01-20 | Sera Prognostics, Inc. | Biomarkers and methods for predicting preterm birth |
WO2017096405A1 (en) * | 2015-12-04 | 2017-06-08 | Nx Prenatal Inc. | Use of circulating microparticles to stratify risk of spontaneous preterm birth |
KR20190046825A (ko) * | 2016-08-05 | 2019-05-07 | 세라 프로그노스틱스 인코포레이티드 | 조기 양막 파열 대 특발성 자연 진통으로 인한 조산 예측용 바이오마커 |
-
2018
- 2018-10-30 JP JP2020543726A patent/JP2021501343A/ja active Pending
- 2018-10-30 TW TW107138397A patent/TW201923347A/zh unknown
- 2018-10-30 WO PCT/EP2018/079639 patent/WO2019086410A1/en unknown
- 2018-10-30 CN CN201880070945.7A patent/CN111542619A/zh active Pending
- 2018-10-30 MX MX2020004421A patent/MX2020004421A/es unknown
- 2018-10-30 BR BR112020008605-3A patent/BR112020008605A2/pt not_active Application Discontinuation
- 2018-10-30 CA CA3080456A patent/CA3080456A1/en not_active Abandoned
- 2018-10-30 EP EP18795580.2A patent/EP3704270A1/en not_active Withdrawn
- 2018-10-30 US US16/758,297 patent/US20200319197A1/en not_active Abandoned
- 2018-10-30 KR KR1020207014208A patent/KR20200094742A/ko not_active Application Discontinuation
- 2018-10-30 SG SG11202003784TA patent/SG11202003784TA/en unknown
- 2018-10-30 AU AU2018357888A patent/AU2018357888A1/en not_active Abandoned
-
2020
- 2020-04-28 IL IL274325A patent/IL274325A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2021501343A (ja) | 2021-01-14 |
KR20200094742A (ko) | 2020-08-07 |
WO2019086410A1 (en) | 2019-05-09 |
CA3080456A1 (en) | 2019-05-09 |
CN111542619A (zh) | 2020-08-14 |
TW201923347A (zh) | 2019-06-16 |
MX2020004421A (es) | 2020-09-25 |
BR112020008605A2 (pt) | 2020-10-06 |
AU2018357888A1 (en) | 2020-05-28 |
US20200319197A1 (en) | 2020-10-08 |
EP3704270A1 (en) | 2020-09-09 |
IL274325A (en) | 2020-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1254669A1 (zh) | 用於預測早產的生物標誌物對 | |
IL254980B (en) | Prognostic and diagnostic glycan-based markers for brain damage | |
HK1258615A1 (zh) | 創傷性腦損傷的生物標誌物 | |
SG10202111841TA (en) | Nanopore-based analysis of protein characteristics | |
GB201511152D0 (en) | Method of diagnosing bladder cancer | |
IL274325A (en) | Biomarkers for preterm birth | |
GB2566681B (en) | Biomarker | |
HK1231555A1 (zh) | 生物標誌物及其用途 | |
HK1251877A1 (zh) | 生物標記和預測方法 | |
SG10202007262PA (en) | Copanlisib biomarkers | |
PL3075862T3 (pl) | Urządzenia i testy do diagnostyki zapalenia zatok przynosowych | |
EP3376229A4 (en) | BIOMARKERS FOR THE DIAGNOSIS OF DEPRESSIONS AND THE USE OF THE BIOMARKER | |
SG10202007322PA (en) | Copanlisib biomarkers | |
GB201504580D0 (en) | Assessment of core samples | |
GB201614455D0 (en) | Biomarkers | |
GB201719639D0 (en) | Setection of biomarkers | |
SG10201913528PA (en) | Methods of diagnosing cancer | |
ZA202001821B (en) | Biomarker | |
GB201704267D0 (en) | Novel biomarker | |
GB201710858D0 (en) | Biomarker | |
IL261906A (en) | Biomarkers for proteopathies and their uses | |
EP3128326A4 (en) | Biomarker for diagnosis of aging or amyotrophia | |
GB201721723D0 (en) | Biomarkers of impaired health | |
GB201707113D0 (en) | Biomarker | |
GB201613912D0 (en) | Predictive biomarker |